Literature DB >> 16831144

The impact of tumour location on the histological subtype of renal cortical tumours.

Lee R Schachter1, Ariadne M Bach, Mark E Snyder, Michael W Kattan, Paul Russo.   

Abstract

OBJECTIVE: To determine whether the location of renal cortical tumours (RCTs) is a possible factor affecting tumour behaviour, by investigating whether exophytic vs a central location is associated with a difference in histological subtype distribution, as recognized prognostic factors for RCTs include size, stage, grade, and histological subtype. PATIENTS AND METHODS: Between 1 January 1996 and 1 June 2003, we evaluated 485 consecutive RCTs in 469 patients who had renal imaging studies and underwent either partial or radical nephrectomy at our institution. A radiologist and a urologist independently reviewed the imaging studies of all patients to determine exophytic vs central location. An exophytic lesion was defined as one that clearly both pushed out the renal contour and did not extend into the collecting system, hilum, or renal sinus. A lesion that did not meet these criteria was defined as a central lesion. Logistic regression analysis was used to determine if either type of lesion had a greater representation of any histological subtype. A two-tailed P < or = 0.05 was considered to indicate significance.
RESULTS: Of the 485 RCTs, 171 (35%) were exophytic and 314 (65%) were central, while 308 (64%) were clear cell and 177 (36%) were non-clear cell tumour histology. Of the exophytic lesions, 52.0% were clear cell, while 69.7% of central lesions were clear cell (P < 0.001). Conversely, 71.1% of clear cell tumours were central, while 53.7% of non-clear cell tumours were central (P = 0.003). After controlling for size and stage, tumour location remained associated with histological subtype (P = 0.003).
CONCLUSIONS: Exophytic lesions are significantly more likely than central lesions to be non-clear cell tumours, and clear cell tumours are significantly more likely than non-clear cell tumours to be central. As studies indicate that the clear cell histological subtype portends a worse prognosis than the non-clear cell subtype, our results imply that tumour location affects the prognosis in RCTs, with exophytic lesions having a better prognosis than central lesions. This result may have important implications for physicians and patients when planning partial vs radical nephrectomy by either open or minimally invasive techniques.

Entities:  

Mesh:

Year:  2006        PMID: 16831144     DOI: 10.1111/j.1464-410X.2006.06179.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  13 in total

1.  Typical signs of oncocytic papillary renal cell carcinoma in everyday clinical praxis.

Authors:  T Urge; O Hes; J Ferda; Z Chudácek; V Eret; M Michal; M Brunelli; G Martignoni; M Hora
Journal:  World J Urol       Date:  2010-05-08       Impact factor: 4.226

2.  Is anatomic complexity associated with renal tumor growth kinetics under active surveillance?

Authors:  Reza Mehrazin; Marc C Smaldone; Brian Egleston; Jeffrey J Tomaszewski; Charles W Concodora; Timothy K Ito; Philip H Abbosh; David Y T Chen; Alexander Kutikov; Robert G Uzzo
Journal:  Urol Oncol       Date:  2015-03-14       Impact factor: 3.498

3.  Anatomic features of enhancing renal masses predict malignant and high-grade pathology: a preoperative nomogram using the RENAL Nephrometry score.

Authors:  Alexander Kutikov; Marc C Smaldone; Brian L Egleston; Brandon J Manley; Daniel J Canter; Jay Simhan; Stephen A Boorjian; Rosalia Viterbo; David Y T Chen; Richard E Greenberg; Robert G Uzzo
Journal:  Eur Urol       Date:  2011-04-01       Impact factor: 20.096

4.  Preoperative predictors of malignancy and unfavorable pathology for clinical T1a tumors treated with partial nephrectomy: a multi-institutional analysis.

Authors:  Mark W Ball; Michael A Gorin; Sam B Bhayani; Craig G Rogers; Michael D Stifelman; Jihad H Kaouk; Homayoun Zargar; Susan Marshall; Jeffrey A Larson; Haider M Rahbar; Bruce J Trock; Phillip M Pierorazio; Mohamad E Allaf
Journal:  Urol Oncol       Date:  2014-12-11       Impact factor: 3.498

5.  Partial versus radical nephrectomy for 4 to 7 cm renal cortical tumors.

Authors:  R Houston Thompson; Sameer Siddiqui; Christine M Lohse; Bradley C Leibovich; Paul Russo; Michael L Blute
Journal:  J Urol       Date:  2009-10-17       Impact factor: 7.450

Review 6.  Functional preservation in patients with renal cortical tumors: the rationale for partial nephrectomy.

Authors:  Paul Russo
Journal:  Curr Urol Rep       Date:  2008-01       Impact factor: 3.092

7.  Patients with anatomically "simple" renal masses are more likely to be placed on active surveillance than those with anatomically "complex" lesions.

Authors:  Jeffrey J Tomaszewski; Robert G Uzzo; Neil Kocher; Tianyu Li; Brandon Manley; Reza Mehrazin; Timothy Ito; Philip Abbosh; Rosalia Viterbo; David Y T Chen; Richard E Greenberg; Daniel Canter; Marc C Smaldone; Alexander Kutikov
Journal:  Urol Oncol       Date:  2014-06-07       Impact factor: 3.498

Review 8.  Active surveillance of small renal masses.

Authors:  Marc C Smaldone; Anthony T Corcoran; Robert G Uzzo
Journal:  Nat Rev Urol       Date:  2013-04-09       Impact factor: 14.432

9.  New Preoperative Nomogram Using the Centrality Index to Predict High Nuclear Grade Clear Cell Renal Carcinoma.

Authors:  Zhan Feng; Shuangshuang Lou; Lixia Zhang; Liang Zhang; Wenting Lan; Minhong Wang; Qijun Shen; Zhengyu Hu; Feng Chen
Journal:  Cancer Manag Res       Date:  2019-12-31       Impact factor: 3.989

10.  Potential role of (124)I-girentuximab in the presurgical diagnosis of clear-cell renal cell cancer.

Authors:  Marc C Smaldone; David Yt Chen; Jian Q Yu; Elizabeth R Plimack
Journal:  Biologics       Date:  2012-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.